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A consecutive series of 78 patients having percutaneous
transluminal coronary angioplasty for single vesselcorp-
nary artery disease and 85 patients having single vessel
coronary artery bypass graft surgery were followed up
prospectively for 1 year. Days in hospital and angio-
graphic and revascularization procedures were counted
in the two groups of patients and total cost of care for
12 months was calculated using current billing levels.
Since its introduction in 1977 (1,2), percutaneous translu-
minal coronary angioplasty has become an established al-
ternative to coronary artery bypass graft surgery for selected
patients with coronary occlusive disease. Advantages of
angioplasty over bypass surgery include avoidance of tho-
racotomy, more prompt recovery and potentially lower cost.
Disadvantages are that patients with initially unsuccessful
angioplasty or with late restenosis (3-5) have more pro-
cedures, extra time in the hospital and increased cost. Al-
though others (6,7) have estimated the economic effect of
initial angioplasty failure and late restenosis, no study has
documented it. The present study compares the actual cost
of coronary angioplasty and bypass surgery in a consecutive
series of patients followed up prospectively from the initial
procedure through the subsequent 12 months.
Methods
Patients. A consecutive series of 1,064 patients referred
for myocardial revascularization form the basis of this study.
Of these, 293 patients had bypass surgery during the IO
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Angioplasty was initially successful in 74% of patients;
because of initial failure in 26% and late restenosis in
18%, bypass surgery was ultimately needed in 23 of 78
patients having coronary angioplasty. Nevertheless, total
cost of care per patient was 43% lower for those having
angioplasty as an initial procedure for single vesselcoro-
nary artery disease.
(J Am Coli CardioI1985;5:16-20)
months before the introduction of angioplasty in our hos-
pital; 51 of these patients had single vessel bypass surgery
(Group I, Table I). The remaining 771 patients had a re-
vascularization procedure during the subsequent 24 months;
of these, 34 had single vessel bypass surgery (Group Ill,
58 had single vessel angioplasty that was initially successful
(Group III) and 20 had an unsuccessful angioplasty attempt
(Group IV). These patients with a single vessel revascular-
ization procedure (Groups I to IV) were followed up pro-
spectively for 12 months both by direct contact and review
of hospital records. One patient having angioplasty (Group
III) and three having bypass surgery (Groups I and II) were
lost to follow-up; thus, 12 month follow-up data were avail-
able for 98% of patients (159 of 163).
Procedures. The indications for revascularization in the
163 patients with single vessel disease were recent onset or
unstable angina, angina not adequately controlled by med-
ical therapy or acute myocardial infarction successfully treated
with intracoronary streptokinase (8). A coronary lesion ap-
propriate for angioplasty was defined as proximal, discrete
and subtotal. Angioplasty was performed using the protocol
and catheter system described by Gruentzig et al. (2). This
initial series of patients was treated with a dilating catheter
having a 5 mm fixed guide wire at its tip (2), and no patient
was treated with more recently introduced steerable guide
wire systems (9). All procedures were performed using the
femoral approach. Successful angioplasty was defined as a
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Table 1. Group Definitions and Clinical Characteristics
Sex Distribution of CADNo. of
Group Patients Treatment Age (yr) (no. men) LAD RCA LCx Grafts
I 5\ CABS 56 ± 10 41 (gCC)() 39 9 0
II 34 CABS 56 ± 9 24 (7\ r;,) 16 12 6 0
III 58 Successful 54 ± g 38 17Wk) 34 21 2 2
PTCA
IV 20 Unsuccessful 53 ± 12 19179%1 \0 9 0
PTCA
CABS = coronary artery bypass surgery; CAD = coronary artery disease; LAD = left anterior descending coronary artery; LCx = left circumflex
coronary artery; PTCA = percutaneous transluminal coronary angioplasty; RCA = right coronary artery.
20% or greater reduction in mean stenosis as measured from
pre- and post-dilation angiograms using two oblique views
whenever possible (2). Drug therapy before and after an-
gioplasty was similar to that reported by Gruentzig et ai.
(2). Patients were routinely monitored with radiotelemetry
after angioplasty, but not in the intensive care unit unless
chest pain was present. Patients having angioplasty were
usually discharged 2 days after the procedure.
Coronary bypass surgery was performed using standard
techniques. The left internal mammary artery was prefer-
entially used to graft the left anterior descending coronary
artery. Follow-up coronary angiography was routinely ad-
vised for patients having successful angioplasty, but not for
patients having bypass surgery.
Statistics. Statistical comparison of categorical data was
performed using the chi-square test, and for continuous vari-
ables using Student's t test for unpaired variables.
Results
Indications for revascularization. There appeared to
be no change in the indication for surgical revascularization
for single vessel coronary artery disease after introduction
of angioplasty. Single vessel bypass surgery was performed
in 51 (18%) of 293 patients in the 10 months before the
angioplasty program was begun, and a single vessel revas-
cularization procedure was performed in 112 (15%) of 771
patients over the subsequent 24 months. During this time.
angioplasty was performed in 78 (10%) of 771 patients.
Clinical characteristics. Age and sex distribution were
simliar in the different study groups (Table I). Distribution
of coronary artery disease also was similar, with a majority
of the patients having left anterior descending coronary ar-
tery disease. The exception was Group II patients who were
judged technically unsuitable for angioplasty and who had
a higher proportion of left circumflex or right coronary artery
disease.
Outcome. Angioplasty was initially successful in 58
(74%) of 78 patients. The success rate was similar for those
with left anterior descending and right coronary artery sten-
oses (Table I). Of 20 patients having unsuccessful angio-
plasty, 18 went directly from the catheterization laboratory
to the operating room for bypass surgery. Eight were having
chest pain at the time of surgery, but only five of these had
ST-T wave changes on the electrocardiogram. Twenty pa-
tients having angioplasty (Groups III and IV) and four hav-
ing bypass surgery (all in Group II) had revascularization
procedures within 5 days of intracoronary streptokinase ther-
apy for acute myocardial infarction. Angioplasty was ini-
tially successful in 15 (75%) of these 20 patients after
infarction.
Operative mortality was low. One patient (Group II) died
as a result of cardiogenic shock after bypass surgery; this
patient had been treated with intracoronary streptokinase for
acute anterior myocardial infarction 2 days before bypass
surgery.
One death could be attributed to angioplasty . This was
a 44 year old man with acute anterior infarction who had
recanalization of an occluded left anterior descending coro-
nary artery after intracoronary streptokinase therapy. Be-
cause of tight stenosis of the proximal segment of the artery,
immediate angioplasty was attempted. The artery was dis-
sected and reoccluded; the patient developed intractable ven-
tricular fibrillation and died. One other patient who had lysis
of an anterior descending artery thrombus with intracoronary
streptokinase remained in cardiogenic shock for 3 days after
infarction; angioplasty was performed successfully, but he
died from persistent cardiogenic shock 36 hours later. There
was no evidence of recurrent ischemia.
To summarize. there were no early deaths from either
angioplasty or bypass surgery in patients with angina pec-
toris. All three early deaths occurred in patients who had
been treated recently with intracoronary streptokinase for
acute myocardial infarction.
Length of hospitalization and return to work. The
length of hospitalization was significantly shorter for Group
III (successful angioplasty) than for any other treatment
group (Table 2). Group IV patients with unsuccessful an-
gioplasty, 18 of whom had immediate bypass surgery, had
a longer average hospital stay than either group having by-
pass surgery alone (Table 2). The excessive mean hospital
stay in Group IV patients occurred as a result of a single
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Table 2. Early Outcome
Work Status
Days in No, With Exercise Return to Eventual
No, of Hospital Status Normal at 3 Working Work S 4 Return to
Group Patients Postop* Weeks Postop Preop Weeks Work
I 51 12 ::!: 7 7 (15%) 36 3 (8%) 34 (95%)
II 34 10 ::!: 4 5 (15%) 22 1 (5%) 19 (86%)
III 58 5 ::!: 4t 83 (57%)t 38 22 (58%)t 38 (100%)
IVt 20 20 ::!: 33 3 (15%) 15 0 15 (100%)
*After the initial procedure. that is, after angioplasty for Group IV patients. tS ignificant compared with values for any other treatment group (p <
0,0 I1. t Eighteen of these 20 patients had coronary artery bypass surgery performed on the day of angioplasty. Postop = after operation; Preop = before
operation,
patient who required 150 days in the hospital because of
femoral artery occlusion after insertion of the intraaortic
balloon pump. Excl uding this patient. postoperative stay for
Group ]V patients was 13 ± 7 days , not significantly longer
than that for other postsurgical patients.
Early recovery was common for patients having suc-
cessf ul angioplasty ; 57% (33 of 58) reported that their ex-
ercise capability had reached or surpassed that at baseline
by 3 weeks after angioplasty (Table 2). In contrast, only
rarely did any patien t having bypass surgery report a return
of exercise status to normal within 3 weeks of surgery . Most
patients in all treatment groups who were employed before
revascularization surgery returned to work. Our general rec-
ommendation for patients having succe ssful angioplasty was
return to work I week after angioplasty, and 16 (42%) did ;
58% had returned to work within I month after angioplasty.
Only rarely did patients having bypass surgery return to
work within I month after surgery .
Long-term follo w-up. Most patients in all treatment
groups did well during the 12 months after revasc ularization
(Tab le 3) . There was one late death after bypass surgery
(Groups] and II) in a patient who had myocardial infarction ,
One patient in Gro up III (successful angioplasty) died sud-
denly while doing unusually heavy work in a snowstorm 6
month s after angioplasty . Angiography 2 months before had
shown no evidence of restenosis . This patient had com-
plained of exertional chest discomfort the week before he
died , but did not seek medical attention .
Myocardial infarction was infrequent (Table 3). Angina
pectoris also was rare among patients having bypass surgery,
and recurrence of angina in eight patients afte r angioplasty
(Group III) reflected restenosis in all cases. The average
number of days in the hospital during the 12 months after
the index hospitalization was higher for patients having an-
gioplasty , but this included routine admission for follow-
up catheterization in 30 asymptomatic patients. When the
routine catheterization and noncardiac admissions were ex-
cluded, total time in the hospital for Group III patients still
was higher as a result of late restenosis in 10 of the 58
patient s. Examination of Group III patient s with and without
late restenosis shows that the former had more hospital
admissions. more time in the hospital and more procedures
(Table 4) .
Comparative costs. Although angioplasty is less ex-
pensive than bypass surgery , primary failure of angioplasty
and late restenosis result in more procedures and more time
in the hospital (Tables 2 to 4) which increase the cost of
care . To evalu ate overall cost of angioplasty relative to
bypass surgery, patients who had bypass surgery as a pri-
mary procedure (Groups I and II) were compared with those
who had angioplasty (Groups III and IV) (Table 5). The
total time in the hospital including postoperative recovery
and hosp italization during the subsequent 12 months was
similar for the two groups, but the data include the patient
described earlier who was in the hospital for 150 day s after
angioplasty . Excluding this patient, patients who had an-
Table 3. Clinical Course During I Year After Discharge After Initial Procedure
No. of Days in Hospital for
Group Patients Death MI Angina Days in Hospital Cardiac Symptoms
I 51 0 2 4 1.4 ::!: 2.8 0.7 :t 2.3
II 34 I I 2 3.8 ::!: 5.6 1.8 ::!: 3.7
III 58 I 0 8 4.3 ::!: 6.3* 2.5 :t 2,6t
IV 20 0 I I 1.5 :t 2,7 0,9 :!: 2,3
*Includes admission for routine follow-up angiography in 30 patients; significantly higher than Groups I and IV (p < 0.06), t lncludes all admissions
for late restenosis. but excludes admission for routine follow-up angiography; significantly higher than Groups I and IV (p < 0,02). MI = myocardial
infarction.
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Table 4. Group Ill: Effect of Late Restenosis After Initially Successful Coronary Angioplasty
No, of Procedures After Initial Angioplasty
Outcome
No restenosis
Late restenosis
No. of
Patients
48
10
No. of
Hospital
Admissions*
(per pt.)
0.7 ± 04
2.1 ± 0.5
p <, 0.001
Days in
Hospital
(per pt.)
2.6 ± 2.1
1\.4 ± 7~
p <..: 0.001
Angiograms
~o
16
PTCA
48
16
CABS
o
5
"Excluding hospitalization at the time of the initial angioplasty and including admission for routine angiography for ~O patients with successful
angioplasty: rnumber of days in hospital during the 12 months after discharge from the initial angioplasty, including hospitalization for routine follow-
up angiography in asymptomatic patients. CABS = coronary artery bypass surgery: pt. = patient: PTCA = percutaneous transluminal coronary
angioplasty.
gioplasty had less time in the hospital (10.6 ± 3.2 versus
13.5 ± 4.2 days, p < 0.02). Patients who had bypass
surgery had more days in the intensive care unit. The number
of angiograms per patient was higher in the angioplasty
group. No patient who had bypass surgery had angioplasty ,
but 23 (28%) of 78 of patients who had angioplasty sub-
sequently had bypass surgery (Table 5).
Patient charges for each item (days in hospital. angio-
gram, angioplasty and bypass surgery) have been multiplied
by their frequency. providing an index of total cost of care
(Table 5). Charges for bypass surgery and angioplasty in-
clude physician fees. Not included in this analysis are lab-
oratory charges and cost of outpatient care. The major sav-
ings are a result of the much lower cost of angioplasty
compared with bypass surgery. When comparing bypass
surgery with angioplasty as the initial revascularization pro-
cedure (Table 5), the total cost of the procedure plus care
over the next 12 months was 43% lower for the average
patient having angioplasty ($7,689 versus $13,559).
Discussion
Clinical course after coronary angioplasty versus by-
pass surgery. The impact of coronary angioplasty can be
viewed in two basic ways. The first is clinical. In our series,
48 (62%) of 78 patients had their symptomatic coronary
Table 5. Cost of Revascularization*
CABS as the Initial Procedure
(Groups I and II: 85 patients)
No. x Costt Total Cost
Days in hospital 969 $250 $242.250
Days in leu 255 $495 $126,225
Angiograms (no.) 9 $1.880 $16,920
PTCA (no.) 0 $3.141
CABS (no.) 86 $8,920 $767.120
Total $1,152.515
Cost per patient $13.559
artery disease successfully treated by angioplasty. This group
of patients had prompt recovery after the procedure and a
shorter hospitalization. Return of exercise capability was
swift, and a majority returned to work within I month. These
results underscore the lower morbidity associated with an-
gioplasty as compared with bypass surgery. When angio-
plasty was not initially successful. most patients underwent
bypass surgery (Group IV). These patients had more days
in the hospital postoperatively than did patients having by-
pass surgery as the initial procedure, but this result was
skewed by one patient (described earlier) who spent 150
days in hospital. In all other respects. the experience of
patients having surgery after unsuccessful angioplasty was
similar to that of others having bypass surgery. Patients with
initially successful angioplasty and late restenosis had prompt
recovery after angioplasty. but restenosis resulted in extra
time in hospital over the next 6 months and multiple pro-
cedures. Although emotional factors were not addressed
specifically by this study, these patients also had additional
anxiety and uncertainty as a result of restenosis.
Effect on cost of care. A second and important impact
of angioplasty is its effect on cost of care. Our results in-
dicate a 43% savings when angioplasty is employed as the
initial procedure for the patient with single vessel coronary
artery disease requiring revascularization. Late restenosis
caused more hospital admissions and procedures for the
PTCA as the Initial Procedure
(Groups 1lI and IV: 78 patients)
No. x Costt Total Cost
880 $250 $220.000
89 $495 $45.055
46 $1.880 $86,480
84 $3,141 $263,844
23 $8,920 $205,160
$599,759
$7,689
*Starting at the time of the initial revascularization procedure (excluding the preoperative diagnostic angiograrns) and for the subsequent 12 months;
tcurrent patient charges, SI. John's Hospital, Springfield, Illinois; includes both hospital and professional charges. CABS = coronary artery bypass
surgery: ICU = intensive care unit: PTCA = percutaneous transluminal coronary angioplasty procedures.
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angioplasty group, thereby increasing overall cost. How-
ever, this was far outweighed by the lower cost of angie-
plasty when compared with bypass surgery (Table 5).
Comparison with previous trials. A difference be-
tween the present study and a multicenter trial of angioplasty
(6,7) is that our clinical follow-up of both angioplasty and
bypass surgery patients was actual rather than estimated.
Days in hospital and procedures were counted, and the eco-
nomic effects of late complications such as failure of bypass
surgery or restenosis after angioplasty were documented. In
the National Cooperative Study (6) of angioplasty, the num-
ber of days in the hospital after either angioplasty or bypass
surgery was similar to that of the present study. That study
also identified restenosis and initial failure of angioplasty
as causes of increased cost (7), but did not quantitate extra
time in hospital and procedures resulting from early or late
angioplasty failure.
Surgical failure rate. When comparing angioplasty with
bypass surgery, the National Cooperative Study (6,7) es-
timated a 10 to 20% failure rate of bypass surgery. Our data
suggest that this estimate is excessive when considering
cost. Bypass graft occlusion rates may be lower for arteries
judged suitable for angioplasty. Although the rate of graft
occlusion was not assessed angiographically in our study,
coronary events after bypass surgery were uncommon, re-
peat angiography was needed infrequently and only one
patient required a second operation. The stable clinical course
of patients during the year after single vessel bypass surgery
observed in this study suggests either the bypass graft oc-
clusion rate is low or that graft occlusion cannot be equated
with clinical failure.
Return to work. Most patients having both angioplasty
and bypass surgery returned to work, which was a result
similar to that reported by Holmes et a1. (10). This unusually
high rate of return to work when compared with other studies
of bypass surgery (11-14) may reflect less extensive coro-
nary artery disease and the relative youth of our patients.
We and others have shown that patients return to work much
sooner after angioplasty than after bypass surgery, resulting
in a greater savings in wages and productivity. These data
were not included in our analysis of savings but further
weight cost consideration in favor of angioplasty.
Future developments. Further development of the tech-
nique of angioplasty may be expected to improve its effec-
tiveness and therefore, savings. Our primary success rate
of 74% for coronary angioplasty is similar to that at other
centers with new angioplasty programs (2,15). Increased
primary success rates with increased operator experience or
new guide wire catheter systems (9) will further increase
savings from angioplasty. In addition, changes in angio-
plasty technique may lower the rate of late restenosis ( I&-18),
which was the single most important contributor to increased
cost of angioplasty. Additional savings may result from
substitution of noninvasive outpatient evaluation of late pa-
tency for routine follow-up angiography (/9). Even with
the inherent problems of a new technique and the dilemma
of late restenosis, our results demonstrate a substantial sav-
ings when angioplasty was used instead of bypass surgery
as the initial revascularization technique for patients with
single vessel coronary artery disease.
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